SPAIN: Puleva Biotech posts 34% rise in H1 net profit
Spanish health food firm Puleva Biotech, a unit of food company Ebro Puleva, has posted a 34% rise in first-half net profit. The company's net profit rose to €932,000 (US$1.06m), while revenue rose 23% to €2.28m. Puleva Biotech said it was to launch a new product on the market in the coming weeks. The firm said tests of its CV-17 food additive showed that in small regular doses it "significantly reduced numerous risk factors connected to heart disease," and the product would go on sale soon, reported Reuters.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 16 years of archives.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- It won't just be Unilever to push for Brexit hikes
- Interview: UK trade body on Brexit's policy impact
- Price an underlying tension across European FMCG
- Danone's Q3 sales - what the analysts say
- Interview: UK trade body on the impact of Brexit
- PepsiCo sets 2025 nutrition, sustainability goals
- Nestle lowers outlook on "softer environment"
- China "transition" drags on Danone Q3
- UK announces "action plan" to drive food exports
- Farmers' groups slam Danone over non-GMO stance